These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26834852)

  • 1. Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
    Loizidou MA; Hadjisavvas A; Tanteles GA; Spanou-Aristidou E; Kyriacou K; Christophidou-Anastasiadou V
    Oncol Lett; 2016 Jan; 11(1):471-473. PubMed ID: 26834852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
    Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
    Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
    Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
    Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
    Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
    Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
    Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
    Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
    Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
    Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
    Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
    Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.
    Miele E; Mastronuzzi A; Po A; Carai A; Alfano V; Serra A; Colafati GS; Strocchio L; Antonelli M; Buttarelli FR; Zani M; Ferraro S; Buffone A; Vacca A; Screpanti I; Giangaspero F; Giannini G; Locatelli F; Ferretti E
    Biomark Res; 2015; 3():13. PubMed ID: 26064523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
    Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
    J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
    Degrolard-Courcet E; Sokolowska J; Padeano MM; Guiu S; Bronner M; Chery C; Coron F; Lepage C; Chapusot C; Loustalot C; Jouve JL; Hatem C; Ferrant E; Martin L; Coutant C; Baurand A; Couillault G; Delignette A; El Chehadeh S; Lizard S; Arnould L; Fumoleau P; Callier P; Mugneret F; Philippe C; Frebourg T; Jonveaux P; Faivre L
    Eur J Hum Genet; 2014 Aug; 22(8):979-87. PubMed ID: 24301060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
    Mori M; Yabe H; Yabe M; Takata M
    Rinsho Ketsueki; 2019; 60(6):691-701. PubMed ID: 31281162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.
    Meyer S; Tischkowitz M; Chandler K; Gillespie A; Birch JM; Evans DG
    J Med Genet; 2014 Feb; 51(2):71-5. PubMed ID: 24259538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.